(Q64922209)

1 July 2019

title

Ruthenium red and capsazepine antinociceptive effect in formalin and capsaicin models of pain in mice. (English)

1 reference

1 July 2019

1 reference

1 reference

1

1 reference

1 July 2019

Joao Batista Calixto

series ordinal

2

1 reference

1 July 2019

language of work or name

English

0 references

publication date

1 October 1997

1 reference

1 July 2019

published in

Neuroscience Letters

1 reference

1 July 2019

volume

235

1 reference

1 July 2019

issue

1-2

1 reference

1 July 2019

page(s)

73-76

1 reference

1 July 2019

Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900722-2

7 January 2021

Evidence for a peripheral origin of the tonic nociceptive response to subcutaneous formalin.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900722-2

7 January 2021

Selective antagonism of capsaicin by capsazepine: evidence for a spinal receptor site in capsaicin-induced antinociception

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900722-2

7 January 2021

Actions of capsaicin on peripheral nociceptors of the neonatal rat spinal cord-tail in vitro: dependence of extracellular ions and independence of second messengers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900722-2

7 January 2021

Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900722-2

7 January 2021

L-NG-nitro arginine methyl ester exhibits antinociceptive activity in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900722-2

7 January 2021

The analgesia induced by intrathecal injection of ruthenium red.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900722-2

7 January 2021

Capsazepine reversal of the antinociceptive action of capsaicin in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900722-2

7 January 2021

Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900722-2

7 January 2021

Inflammation and hyperalgesia in rats neonatally treated with capsaicin: effects on two classes of nociceptive neurons in the superficial dorsal horn

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900722-2

7 January 2021

The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900722-2

7 January 2021

Antinociception induced by CP 96,345, a non-peptide NK-1 receptor antagonist, in the mouse formalin and capsaicin tests

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900722-2

7 January 2021

Further evidence for the involvement of tachykinin receptor subtypes in formalin and capsaicin models of pain in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900722-2

7 January 2021

The formalin test: an evaluation of the method

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900722-2

7 January 2021

Evidence that glutamate is released from capsaicin-sensitive primary afferent fibers in rats: study with on-line continuous monitoring of glutamate

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900722-2

7 January 2021

Capsazepine, a novel capsaicin antagonist, selectively antagonises the effects of capsaicin in the mouse spinal cord in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900722-2

7 January 2021

Ethical guidelines for investigations of experimental pain in conscious animals

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900722-2

7 January 2021

10.1016/S0304-3940(97)00722-2

Identifiers

DOI

1 reference

1 July 2019

1 reference

1 July 2019